• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对接受间歇性雄激素抑制治疗的前列腺癌患者 PSA 动力学的定量数学建模。

Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression.

机构信息

Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.

出版信息

J Mol Cell Biol. 2012 Jun;4(3):127-32. doi: 10.1093/jmcb/mjs020. Epub 2012 May 4.

DOI:10.1093/jmcb/mjs020
PMID:22561841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3612008/
Abstract

If a mathematical model is to be used in the diagnosis, treatment, or prognosis of a disease, it must describe the inherent quantitative dynamics of the state. An ideal candidate disease is prostate cancer owing to the fact that it is characterized by an excellent biomarker, prostate-specific antigen (PSA), and also by a predictable response to treatment in the form of androgen suppression therapy. Despite a high initial response rate, the cancer will often relapse to a state of androgen independence which no longer responds to manipulations of the hormonal environment. In this paper, we present relevant background information and a quantitative mathematical model that potentially can be used in the optimal management of patients to cope with biochemical relapse as indicated by a rising PSA.

摘要

如果一个数学模型要用于疾病的诊断、治疗或预后,它必须描述状态的内在定量动态。前列腺癌是一个理想的候选疾病,因为它具有一个极好的生物标志物,即前列腺特异性抗原(PSA),并且也具有以雄激素抑制治疗形式出现的可预测的治疗反应。尽管初始反应率很高,但癌症通常会复发到雄激素不依赖的状态,不再对激素环境的操作产生反应。在本文中,我们介绍了相关的背景信息和一个定量数学模型,该模型可能用于患者的最佳管理,以应对 PSA 升高所表明的生化复发。

相似文献

1
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression.对接受间歇性雄激素抑制治疗的前列腺癌患者 PSA 动力学的定量数学建模。
J Mol Cell Biol. 2012 Jun;4(3):127-32. doi: 10.1093/jmcb/mjs020. Epub 2012 May 4.
2
Treatment of locally advanced prostate cancer (Stage T3).局部晚期前列腺癌(T3期)的治疗
Jpn J Clin Oncol. 2017 Mar 1;47(3):257-261. doi: 10.1093/jjco/hyw186.
3
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.雄激素剥夺治疗时机对 PSA 升高的前列腺癌患者的影响(TROG 03.06 和 VCOG PR 01-03 [TOAD]):一项随机、多中心、非盲、3 期临床试验。
Lancet Oncol. 2016 Jun;17(6):727-737. doi: 10.1016/S1470-2045(16)00107-8. Epub 2016 May 4.
4
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.醋酸阿比特龙联合泼尼松治疗非转移性生化复发的去势敏感前列腺癌。
Eur J Cancer. 2021 Nov;157:259-267. doi: 10.1016/j.ejca.2021.06.017. Epub 2021 Sep 15.
5
Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome.前列腺癌间歇性雄激素抑制疗法的渥太华II期研究的成熟结果:预后的临床预测因素
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):699-706. doi: 10.1016/j.ijrobp.2006.12.072. Epub 2007 Mar 26.
6
Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling.利用数学模型为前列腺癌进行个体化雄激素抑制治疗。
Sci Rep. 2018 Feb 8;8(1):2673. doi: 10.1038/s41598-018-20788-1.
7
Optimization Therapy by Coupling Intermittent Androgen Suppression with Impulsive Chemotherapy for a Prostate Cancer Model.间歇性雄激素抑制联合冲动化疗治疗前列腺癌模型的优化治疗。
Bull Math Biol. 2023 Nov 7;85(12):123. doi: 10.1007/s11538-023-01228-2.
8
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.局部或局部晚期前列腺癌男性患者接受放疗和雄激素抑制治疗后前列腺癌特异性死亡率的替代终点:两项随机试验分析。
Lancet Oncol. 2012 Feb;13(2):189-95. doi: 10.1016/S1470-2045(11)70295-9. Epub 2011 Nov 21.
9
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.局部晚期前列腺癌男性患者中短期雄激素抑制联合放疗与中期雄激素抑制联合放疗、联合或不联合唑来膦酸的比较(TROG 03.04 RADAR):一项开放标签、随机、3 期析因试验。
Lancet Oncol. 2014 Sep;15(10):1076-89. doi: 10.1016/S1470-2045(14)70328-6. Epub 2014 Aug 14.
10
Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer.解读雄激素剥夺治疗复发性前列腺癌时的睾酮和前列腺特异性抗原值。
J Urol. 2021 Nov;206(5):1166-1176. doi: 10.1097/JU.0000000000001946. Epub 2021 Jun 29.

引用本文的文献

1
Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice.基于临床实践数据估算前列腺切除术后患者进行前列腺特异性膜抗原正电子发射断层扫描的最佳时间
Biom J. 2025 Jun;67(3):e70058. doi: 10.1002/bimj.70058.
2
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer.优化标准护理疗法以延缓耐药性骨转移性前列腺癌的出现并进行量化分析
Cancers (Basel). 2021 Feb 8;13(4):677. doi: 10.3390/cancers13040677.
3
Modeling the Human Bone-Tumor Niche: Reducing and Replacing the Need for Animal Data.模拟人类骨肿瘤微环境:减少并替代对动物数据的需求。
JBMR Plus. 2020 Mar 23;4(4):e10356. doi: 10.1002/jbm4.10356. eCollection 2020 Apr.
4
Massive computational acceleration by using neural networks to emulate mechanism-based biological models.利用神经网络模拟基于机制的生物模型实现大规模计算加速。
Nat Commun. 2019 Sep 25;10(1):4354. doi: 10.1038/s41467-019-12342-y.
5
PAGE4 and Conformational Switching: Insights from Molecular Dynamics Simulations and Implications for Prostate Cancer.第四页和构象转换:来自分子动力学模拟的见解及其对前列腺癌的影响。
J Mol Biol. 2018 Aug 3;430(16):2422-2438. doi: 10.1016/j.jmb.2018.05.011. Epub 2018 Jun 5.
6
Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling.利用数学模型为前列腺癌进行个体化雄激素抑制治疗。
Sci Rep. 2018 Feb 8;8(1):2673. doi: 10.1038/s41598-018-20788-1.
7
A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study.一项关于数据与可识别性的信心建立练习:以癌症化疗建模为例进行研究。
J Theor Biol. 2017 Oct 27;431:63-78. doi: 10.1016/j.jtbi.2017.07.018. Epub 2017 Jul 19.
8
Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin.接受艾瑞布林治疗的去势抵抗性前列腺癌患者的疾病进展/临床结局模型
CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):386-95. doi: 10.1002/psp4.49. Epub 2015 Jun 30.
9
Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.间歇性雄激素抑制:根据雄激素剥夺治疗初始前列腺特异性抗原(PSA)数据估算个体患者参数
PLoS One. 2015 Jun 24;10(6):e0130372. doi: 10.1371/journal.pone.0130372. eCollection 2015.
10
Predicting disease progression from short biomarker series using expert advice algorithm.使用专家建议算法从简短生物标志物序列预测疾病进展。
Sci Rep. 2015 May 20;5:8953. doi: 10.1038/srep08953.

本文引用的文献

1
Mathematically modelling and controlling prostate cancer under intermittent hormone therapy.数学建模与间歇性激素治疗下前列腺癌的控制。
Asian J Androl. 2012 Mar;14(2):270-7. doi: 10.1038/aja.2011.155. Epub 2012 Jan 9.
2
Nonlinear systems identification by combining regression with bootstrap resampling.基于回归与自举重采样结合的非线性系统辨识。
Chaos. 2011 Dec;21(4):043121. doi: 10.1063/1.3657919.
3
Mathematical modeling of prostate cancer progression in response to androgen ablation therapy.雄激素剥夺疗法治疗前列腺癌进展的数学模型。
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19701-6. doi: 10.1073/pnas.1115750108. Epub 2011 Nov 21.
4
Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer.前列腺癌间歇性雄激素抑制的混合优化调度。
Chaos. 2010 Dec;20(4):045125. doi: 10.1063/1.3526968.
5
Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.通过个性化的数学模型预测前列腺癌免疫治疗的结果。
PLoS One. 2010 Dec 8;5(12):e15482. doi: 10.1371/journal.pone.0015482.
6
Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer.分段仿射系统建模用于优化前列腺癌的激素治疗。
Philos Trans A Math Phys Eng Sci. 2010 Nov 13;368(1930):5045-59. doi: 10.1098/rsta.2010.0220.
7
Mathematical modelling of prostate cancer growth and its application to hormone therapy.前列腺癌生长的数学建模及其在激素治疗中的应用。
Philos Trans A Math Phys Eng Sci. 2010 Nov 13;368(1930):5029-44. doi: 10.1098/rsta.2010.0221.
8
Theory of hybrid dynamical systems and its applications to biological and medical systems.混合动态系统理论及其在生物和医学系统中的应用。
Philos Trans A Math Phys Eng Sci. 2010 Nov 13;368(1930):4893-914. doi: 10.1098/rsta.2010.0237.
9
Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.在一项间歇性雄激素剥夺治疗前列腺癌生化复发的前瞻性试验中,首次治疗间隔时间的持续时间是预测去势抵抗和死亡时间的预后因素。
J Clin Oncol. 2010 Jun 1;28(16):2668-73. doi: 10.1200/JCO.2009.25.1330. Epub 2010 Apr 26.
10
The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.雄激素水平对多尺度数学模型中前列腺癌的进化影响。
Biol Direct. 2010 Apr 20;5:24. doi: 10.1186/1745-6150-5-24.